The Risks of Health E-Cigarettes: Safety Concerns Arise

Sep.07.2022
The Risks of Health E-Cigarettes: Safety Concerns Arise
Healthy" e-cigarettes, containing vitamins and oils, are growing in popularity but lack safety testing and may have long-term risks.

The so-called health electronic cigarettes are becoming increasingly popular. Unlike regular electronic cigarettes that contain nicotine, these products contain vitamins or essential oils. However, they have caught the attention of the US Food and Drug Administration (FDA).


Healthy electronic cigarettes, also known as 'nutritional supplement diffusers,' encompass a range of products that share a common source found in electronic cigarettes. Unlike traditional cigarettes, electronic cigarettes deliver nicotine to the lungs without combustion or tobacco. This allows for the removal of harmful ingredients such as tobacco tar. Electronic cigarettes work by utilizing energy from a battery to heat liquid, creating an inhalable vapor.


A new line of products aims to use the same inhalation delivery system for various non-nicotine products, including popular vitamins (such as B12 and C), milk thistle, melatonin (a hormone), green tea, and various essential oils. The health e-cigarette company claims that different combinations of these additives can help improve focus, promote sleep, and even aid in weight loss.


Inhaling rather than swallowing these compounds allows for quicker absorption into the bloodstream, hence theoretically making vitamins and supplements more effective when inhaled.


Many of these additives will be familiar as supplements deemed safe for ingestion. However, most lack inhalation safety testing, particularly in regards to potential long-term harm. Because healthy e-cigarettes do not contain nicotine, they have managed to evade regulatory agencies.


The onset of the 2019 outbreak of e-cigarette or vaping product use associated lung injury (or EVALI) in the United States highlighted the importance of detecting ingestion methods. In the initial report of 60 deaths related to EVALI, vitamin E acetate was identified as a key factor causing lung damage in these individuals. Vitamin E is a common food additive, therefore this clearly emphasizes that even well-known healthy substances can have serious consequences on one's health when inhaled.


These devices are quite innovative in the market, and therefore research on their safety is scarce. Administering incorrect patient groups with untested methods could render many benign or beneficial compounds harmful. For example, the benefits of vitamin C are well-known, but using high doses of vitamin C has been shown to increase the risk of death in sepsis patients.


Vitamin B12 is also a popular additive in these devices. B12 injections are highly effective in restoring vitamin levels for those who are deficient. However, there is no evidence to support any benefits for people with normal B12 levels. Additionally, we lack evidence on the safety or efficacy of inhaling B12.


A research conducted in 1967 revealed that inhaling vitamin B12 showed no benefits compared to injecting supplements. However, even at that time, researchers pointed out the potential risk of lung damage.


We can also examine information on components commonly shared with electronic cigarettes to identify potential impacts. Some products offer Vitamin B12 dissolved in vegetable glycerin, a common ingredient in e-liquids. Other products use propylene glycol or a mixture of two liquids. When heated, these components can break down into harmful chemicals known as reactive carbonyl compounds, such as formaldehyde.


These chemicals have been found to damage alveolar macrophages, which are crucial immune cells in the lungs, in a manner that does not depend on the presence of nicotine. Similar findings have been observed in other important airway and immune cells.


Electronic cigarettes that offer essential oils as a healthier option may also be subject to similar issues. They contain a mixture of compounds known as terpenes, as well as other chemicals similar to those found in e-liquids.


According to reports, terpenes have a range of benefits, including anti-cancer, anti-allergy and antibacterial properties, indicating potential benefits of taking these essential oils. However, terpenes can be degraded by heat and may be broken down into harmful compounds when inhaled, which can irritate the respiratory tract and potentially be toxic to cells at higher doses and longer exposure times.


Due to the similarities between electronic cigarettes and health e-cigarettes, these companies are now facing increasingly strict scrutiny from public health institutions. The FDA warns that health e-cigarettes are "unsafe," "ineffective," and "unproven.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only intended for industry exchange and research.


Due to the limitations of the translator’s skills, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government's stance and statements on any issues related to domestic, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
DOJO officially launched the BLAST7K Fresh on September 17, 2026, introducing a UK-market prefilled pod product with 6ml of e-liquid and a manufacturer-rated capacity of up to 7,000 puffs. The device features a 1000mAh rechargeable battery, the INSTA-JUICED structure and COREX BLAST dual-mesh technology, while retaining compatibility with existing BLAST pods. The launch comes less than two weeks before the UK's Vaping Products Duty takes effect on October 1. At the new duty rate, 6ml of vaping liquid would correspond to £1.32 in VPD. DOJO has not stated that the product's 6ml format was designed in response to the new duty.
Sep.20
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
The UK Department of Health and Social Care published new guidance on Aug. 11 outlining the next phase of retail rules under the Tobacco and Vapes Act 2026, which will take effect on Oct. 29, 2026. The measures extend the minimum age of sale of 18 to all vaping and consumer nicotine products and restrict proxy purchasing, promotional giveaways and substantial discounts. Relevant offences in England, Wales and Scotland may carry a £200 fixed penalty notice, while persistent offenders can face temporary sales bans.
Aug.12
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
At InterTabac 2026 in Dortmund, China Tobacco International (HK) Company Limited (CTIHK) is exhibiting across two separate booths in Hall 5 and Hall 4. Products observed by 2Firsts include heated tobacco products, nicotine pouches, Chinese cigars and tobacco leaf. Nicotine pouch products on display include TOOP, Shuangxi and Ashima.
Market
Sep.16